MedPath

Carbon Dioxide Acupulse Laser Treatment Versus Sham Treatment and Stress Urinary Incontinence Symptoms

Not Applicable
Completed
Conditions
Stress Urinary Incontinence
Interventions
Device: sham laser
Device: carbon dioxide laser
Registration Number
NCT05097456
Lead Sponsor
Rambam Health Care Campus
Brief Summary

The study is intended to assess the safety and efficacy of Carbon dioxide AcuPulse laser treatment in patients with stress urinary incontinence. Eligible subjects will be randomized to either receive 3 laser or 3 sham treatment sessions, 4 weeks apart and 3 follow up visits 3, 6 and 12 months following the last treatment.

Detailed Description

Following a screening visit, eligible subjects will be enrolled into the study. Subjects will be randomized into either laser treatment or sham treatment. Each subject will receive 3 treatments 4 weeks apart and 3 follow up visits, at 3, 6 and 12 months following the last treatment.

Further demographic information and patient history will be obtained from the subjects' electronic files.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
125
Inclusion Criteria
  • Negative urine analysis.
  • Normal Pap smear test from the recent 3 years.
  • No previous gynecological laser treatments.
  • Able and willing to comply with the treatment/follow-up schedule and requirements.
Exclusion Criteria
  • Active genital infection.
  • Subject presenting abnormal Pap result from the last three years.
  • Recurring urinary tract infection or recurring infection of genital herpes or candida (> 2 episodes in the recent year).
  • Transvaginal mesh implant.
  • Serious systemic disease or any chronic condition that could interfere with study compliance.
  • Any vaginal bleeding of unknown reason.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sham treatmentsham lasersham treatment
Laser treatmentcarbon dioxide lasercarbon dioxide treatment
Primary Outcome Measures
NameTimeMethod
Pad weight testFrom treatment up to 12 months post treatment

Change in pad weight

Secondary Outcome Measures
NameTimeMethod
Urinary distress index questionnaireFrom treatment up to 12 months post treatment

Change in urinary distress index questionnaire scores

Cough testFrom treatment up to 12 months post treatment

Positive cough test

International consultation on incontinence questionnaire-urinary incontinenceFrom treatment up to 12 months post treatment

Change in international consultation on incontinence questionnaire-urinary incontinence scores

Pelvic organ prolapse/urinary incontinence sexual questionnaireFrom treatment up to 12 months post treatment

Change in pelvic organ prolapse/urinary incontinence sexual questionnaire scores

Trial Locations

Locations (1)

Rambam health care campus

🇮🇱

Haifa, Israel

© Copyright 2025. All Rights Reserved by MedPath